Correlation Between Denali Therapeutics and Milestone Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Denali Therapeutics and Milestone Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Denali Therapeutics and Milestone Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Denali Therapeutics and Milestone Pharmaceuticals, you can compare the effects of market volatilities on Denali Therapeutics and Milestone Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Denali Therapeutics with a short position of Milestone Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Denali Therapeutics and Milestone Pharmaceuticals.
Diversification Opportunities for Denali Therapeutics and Milestone Pharmaceuticals
0.01 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Denali and Milestone is 0.01. Overlapping area represents the amount of risk that can be diversified away by holding Denali Therapeutics and Milestone Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Milestone Pharmaceuticals and Denali Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Denali Therapeutics are associated (or correlated) with Milestone Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Milestone Pharmaceuticals has no effect on the direction of Denali Therapeutics i.e., Denali Therapeutics and Milestone Pharmaceuticals go up and down completely randomly.
Pair Corralation between Denali Therapeutics and Milestone Pharmaceuticals
Given the investment horizon of 90 days Denali Therapeutics is expected to under-perform the Milestone Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Denali Therapeutics is 1.16 times less risky than Milestone Pharmaceuticals. The stock trades about -0.05 of its potential returns per unit of risk. The Milestone Pharmaceuticals is currently generating about 0.34 of returns per unit of risk over similar time horizon. If you would invest 148.00 in Milestone Pharmaceuticals on September 4, 2024 and sell it today you would earn a total of 52.00 from holding Milestone Pharmaceuticals or generate 35.14% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Denali Therapeutics vs. Milestone Pharmaceuticals
Performance |
| Timeline |
| Denali Therapeutics |
| Milestone Pharmaceuticals |
Denali Therapeutics and Milestone Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Denali Therapeutics and Milestone Pharmaceuticals
The main advantage of trading using opposite Denali Therapeutics and Milestone Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Denali Therapeutics position performs unexpectedly, Milestone Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Milestone Pharmaceuticals will offset losses from the drop in Milestone Pharmaceuticals' long position.| Denali Therapeutics vs. Candel Therapeutics | Denali Therapeutics vs. Cingulate Warrants | Denali Therapeutics vs. Unicycive Therapeutics | Denali Therapeutics vs. Quoin Pharmaceuticals Ltd |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Complementary Tools
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |